Tests to assist in the diagnosis of oral cancer can be invasive, and sometimes inappropriate for detecting cancer in its early stages. Saliva tests can be an effective, non-invasive pre-diagnostic tool.
The BeVigilant™ OraFusion™ System from Vigilant Biosciences® is a non-invasive fluoroscopic and visual saliva biomarker-based semi-quantitative risk assessment tool which is intended to be used during examination, without the use of a tissue biopsy. In 15 minutes or less, the BeVigilant™ OraFusion™ System easily identifies the presence of biomarkers associated with oral cancer and produces a report of either low, moderate, or elevated risk levels to assist dentists in their decision making.
To discover more about this pre-diagnostic testing system, please visit the website or get in touch today.
For more information, please visit www.vigilantbiosciences.com or email info@vigilantbiosciences.com
